PO.BCS01.09 · 生物信息与计算
从动物到计算肿瘤学:数字孪生作为下一代骨转移研究的伦理推动者
From animals to computational oncology: Digital twins as ethical enablers of next-generation bone metastasis research
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
骨转移(BM)是晚期前列腺癌和肾癌患者的致命后果,显著导致发病率升高、死亡风险增加和沉重的医疗负担。体内生物学实验提供了支持癌症进展和治疗应答的细胞机制证据,但它们在以时间-成本高效的方式应对BM的多参数复杂性方面存在局限,并且引发关于伤害和痛苦的伦理担忧。相反,计算机模拟计算模型可以探索无限数量的实验组合,避免时间和资源消耗,为研究疾病生物学和微环境相互作用提供了宝贵的替代方案。因此,本工作引入数字孪生来监测BM进展、对治疗的应答以及对骨力学性能的影响。通过结合三维多光子显微镜和计算机模拟建模,我们生成了受体内启发、空间显式、多细胞的A(BM)²(BM的基于智能体模型),复现了肿瘤生长、血管生成和骨吸收。我们利用来自前列腺和肾脏肿瘤的体内数据严格获取驱动系数,并通过随机森林回归算法对其进行校准,使其符合体内生长速率。我们进一步通过模拟cabozantinib的抗血管生成效应和zoledronic acid的抗骨吸收效应进行了稳健的双重验证。我们的结果凸显了A(BM)²在预测治疗结局方面的预测能力,并增进了我们对BM复杂动态的理解。同时,我们开发了一个用于长骨和椎骨力学测试的数字孪生,它将有限元分析与micro-CT衍生的骨几何结构和材料属性相整合。计算压缩测试揭示了在使用骨靶向药物Radium-223治疗后小梁骨的脆性增加,而三点弯曲测试显示治疗后皮质骨没有脆性。然而,它们确实揭示了骨溶解发生后脆性显著增加,表明这些互补方法提供了对骨力学完整性的全面理解。总之,我们的数字孪生方法提供了一个变革性平台,用于剖析肿瘤进展、预测治疗应答并评估对骨力学的影响。通过在计算机模拟中实现这些见解,我们旨在显著减少对动物模型的依赖,直接支持并加强3Rs原则。
查看英文原文 English abstract
Bone metastasis (BM) is a lethal consequence for advanced prostate and renal cancer patients, contributing significantly to morbidity, elevated mortality risk, and substantial healthcare burden. In vivo biological experiments provide evidence of the cellular mechanisms supporting cancer progression and therapy response, but they are limited in addressing the multi-parameter complexity of BM in a time-cost effective manner and pose ethical concerns about harm and distress. In silico computational models, instead, can explore an unlimited number of experimental combinations avoiding time and resource consumption, providing a valuable alternative to investigate disease biology and microenvironment interactions. Accordingly, this work introduces digital twins to monitor BM progression, response to therapy and impact on bone mechanical properties. By combining three-dimensional multiphoton microscopy and in silico modeling, we generated in vivo inspired, spatially explicit, multicellular A(BM)²s (Agent-Based Models of BM) replicating tumor growth, angiogenesis, and bone resorption. We rigorously retrieved driving coefficients using in vivo data from prostate and kidney tumors and calibrated them through a random forest regressor algorithm to adhere to the in vivo growth rate. We further conducted robust double verification by simulating both the anti-angiogenic effects of cabozantinib and the anti-resorptive effects of zoledronic acid. Our results highlight the predictive character of our A(BM)² in anticipating therapeutic outcomes and increasing our understanding of the complex dynamics of BM. In parallel, we developed a digital twin for mechanical testing of long bones and vertebrae that integrates finite element analysis with micro-CT-derived bone geometry and material properties. Computational compression tests revealed increased fragility in trabecular bone following treatment with the bone-targeting agent Radium-223, whereas three-point bending tests showed no fragility in cortical bone post-treatment. However, they did reveal significantly increased fragility after osteolysis occurred, indicating that these complementary approaches provide a comprehensive understanding of bone mechanical integrity. Overall, our digital twin approach provides a transformative platform to dissect tumor progression, predict therapy response, and evaluate the consequences on bone mechanics. By enabling these insights in silico, we aim to significantly reduce dependence on animal models, directly supporting and strengthening the 3Rs principle.
利益披露 Disclosure
L. Marsilio, None..
S. Maksimovic, None..
E. Serafini, None..
A. Maccarini, None..
S. Barrios, None..
P. Cerveri, None..
S. Casarin, None.
E. Dondossola,
Bayer ).